Robert A. Kyle, MD
Disclaimer: This editorial does not imply that Mayo Foundation endorses any of the products mentioned therein.
Disclosure: Dr. Kyle is on the Speaker's Bureau of OrthoBiotech, Schering-Plough, and Novartis. He also serves as a consultant to Hoffman-LaRoche.
Grant Support: In part by National Cancer Institute grant CA62242.
Requests for Single Reprints: Robert A. Kyle, MD, Mayo Clinic, 200 First Street SW, Rochester, MN 55905.
Requests To Purchase Bulk Reprints (minimum, 100 copies): the Reprints Coordinator; phone, 215-351-2657; e-mail, firstname.lastname@example.org.
Kyle RA. The Role of Bisphosphonates in Multiple Myeloma. Ann Intern Med. 2000;132:734–736. doi: https://doi.org/10.7326/0003-4819-132-9-200005020-00009
Download citation file:
Published: Ann Intern Med. 2000;132(9):734-736.
Hematology/Oncology, Multiple Myeloma.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use